Literature DB >> 26449998

Determinants of Effort Intolerance in Patients With Heart Failure: Combined Echocardiography and Cardiopulmonary Stress Protocol.

Jason Shimiaie1, Jack Sherez1, Galit Aviram2, Ricki Megidish1, Sami Viskin1, Amir Halkin1, Meirav Ingbir1, Nahum Nesher3, Simon Biner1, Gad Keren1, Yan Topilsky4.   

Abstract

OBJECTIVES: The purpose of this study was to assess individual mechanisms of effort intolerance in patients with heart failure with preserved ejection fraction (HFpEF), heart failure with reduced ejection fraction (HFrEF), or normal cardiac function using combined echocardiography and cardiopulmonary stress testing.
BACKGROUND: Combined stress echocardiography and cardiopulmonary tests visualize cardiac chambers in 4 well-defined activity levels (rest, unloaded, anaerobic threshold, and peak), allowing noninvasive assessment of cardiac function, hemodynamics, and arterial venous oxygen content difference (AVo(2)Diff) during all stages.
METHODS: Left ventricular volumes, stroke volume (SV), S', E/e', oxygen consumption (Vo(2)), and AVo(2)Diff were measured in all effort stages using ramp semirecumbent cycle prolonged (≥8 min) exercise in 45 consecutive subjects evaluated for effort intolerance (14 normal cardiac function, 16 HFpEF, and 15 HFrEF patients; age 56.5 ± 16 years; 73% male).
RESULTS: In HFpEF and HFrEF, the changes in Vo2 were attenuated (between group p = 0.003; group by time interaction p < 0.0001), as well as peak heart rate (p = 0.0001; p = 0.0001) and SV (p = 0.006; p = 0.0001). End-diastolic volume to E/e' ratio (measure of compliance) was superior in HFrEF and normal patients at baseline but worsened in HFpEF and HFrEF at peak exercise (8.3 ± 4 vs. 11.6 ± 5 vs. 19.1 ± 8; p = 0.004; p = 0.01). Functional mitral regurgitation worsened even during the unloaded stage, mostly in patients with HFrEF, but also in several patients with HFpEF. In multivariable analysis, heart rate response (p = 0.007), and AVo(2)Diff (p < 0.0001) were the most significant independent predictors of effort capacity; SV was not.
CONCLUSIONS: Combined tests are feasible and allow noninvasive evaluation of effort intolerance. In HFpEF and HFrEF patients, exercise intolerance is predominantly due to chronotropic incompetence and peripheral factors. Combined stress echocardiography and cardiopulmonary tests may have potential for clinical management and selection of patients for trials.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  congestive heart failure; echocardiography; exercise testing

Mesh:

Year:  2015        PMID: 26449998     DOI: 10.1016/j.jchf.2015.05.010

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  23 in total

Review 1.  Heart failure with preserved ejection fraction and skeletal muscle physiology.

Authors:  Stephen D Farris; Farid Moussavi-Harami; April Stempien-Otero
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

Review 2.  Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction.

Authors:  Marty C Tam; Ran Lee; Thomas M Cascino; Matthew C Konerman; Scott L Hummel
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

3.  Cardiac and Noncardiac Determinants of Exercise Capacity in CKD.

Authors:  Shanmugakumar Chinnappa; Nigel Lewis; Omer Baldo; Ming-Chieh Shih; Yu-Kang Tu; Andrew Mooney
Journal:  J Am Soc Nephrol       Date:  2021-06-18       Impact factor: 14.978

Review 4.  Heart Failure With Preserved Ejection Fraction: A Perioperative Review.

Authors:  Sasha K Shillcutt; M Megan Chacon; Tara R Brakke; Ellen K Roberts; Thomas E Schulte; Nicholas Markin
Journal:  J Cardiothorac Vasc Anesth       Date:  2017-08-30       Impact factor: 2.628

Review 5.  Relative Impairments in Hemodynamic Exercise Reserve Parameters in Heart Failure With Preserved Ejection Fraction: A Study-Level Pooled Analysis.

Authors:  Ambarish Pandey; Rohan Khera; Bryan Park; Mark Haykowsky; Barry A Borlaug; Gregory D Lewis; Dalane W Kitzman; Javed Butler; Jarett D Berry
Journal:  JACC Heart Fail       Date:  2018-02       Impact factor: 12.035

Review 6.  The link between exercise and titin passive stiffness.

Authors:  Sophie Lalande; Patrick J Mueller; Charles S Chung
Journal:  Exp Physiol       Date:  2017-07-31       Impact factor: 2.969

7.  Stress echo 2020: the international stress echo study in ischemic and non-ischemic heart disease.

Authors:  Eugenio Picano; Quirino Ciampi; Rodolfo Citro; Antonello D'Andrea; Maria Chiara Scali; Lauro Cortigiani; Iacopo Olivotto; Fabio Mori; Maurizio Galderisi; Marco Fabio Costantino; Lorenza Pratali; Giovanni Di Salvo; Eduardo Bossone; Francesco Ferrara; Luna Gargani; Fausto Rigo; Nicola Gaibazzi; Giuseppe Limongelli; Giuseppe Pacileo; Maria Grazia Andreassi; Bruno Pinamonti; Laura Massa; Marco A R Torres; Marcelo H Miglioranza; Clarissa Borguezan Daros; José Luis de Castro E Silva Pretto; Branko Beleslin; Ana Djordjevic-Dikic; Albert Varga; Attila Palinkas; Gergely Agoston; Dario Gregori; Paolo Trambaiolo; Sergio Severino; Ayana Arystan; Marco Paterni; Clara Carpeggiani; Paolo Colonna
Journal:  Cardiovasc Ultrasound       Date:  2017-01-18       Impact factor: 2.062

Review 8.  Targeting Endothelial Function to Treat Heart Failure with Preserved Ejection Fraction: The Promise of Exercise Training.

Authors:  Andreas B Gevaert; Katrien Lemmens; Christiaan J Vrints; Emeline M Van Craenenbroeck
Journal:  Oxid Med Cell Longev       Date:  2017-06-19       Impact factor: 6.543

9.  No effect of endoperoxide 4 or thromboxane A2 receptor blockade on static mechanoreflex activation in rats with heart failure.

Authors:  Alec L E Butenas; Korynne S Rollins; Jacob E Matney; Auni C Williams; Talyn E Kleweno; Shannon K Parr; Stephen T Hammond; Carl J Ade; Karen S Hageman; Timothy I Musch; Steven W Copp
Journal:  Exp Physiol       Date:  2020-10-06       Impact factor: 2.969

10.  Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes.

Authors:  Lorenzo Nesti; Nicola Riccardo Pugliese; Paolo Sciuto; Nicolò De Biase; Matteo Mazzola; Iacopo Fabiani; Domenico Trico; Stefano Masi; Andrea Natali
Journal:  Cardiovasc Diabetol       Date:  2021-06-22       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.